Zdrowie i gospodarka · 01/12/2021

FDA Renews Patient Engagement Advisory Committee for 2 Additional Years

The Food and Drug Administration (FDA) is renewing the Patient Engagement Advisory Committee for an additional 2 years, with the new charter set to expire on October 6, 2023, following a determination by the Commissioner of Food and Drugs.